Compare PLAY & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLAY | AMRN |
|---|---|---|
| Founded | 1982 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | 80 |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.3M | 287.9M |
| IPO Year | 2011 | 1998 |
| Metric | PLAY | AMRN |
|---|---|---|
| Price | $8.72 | $13.63 |
| Analyst Decision | Buy | Strong Sell |
| Analyst Count | 6 | 1 |
| Target Price | ★ $23.83 | $12.00 |
| AVG Volume (30 Days) | ★ 1.4M | 72.7K |
| Earning Date | 06-09-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ 0.16 | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | $5.57 | N/A |
| Revenue Next Year | $5.00 | $1.26 |
| P/E Ratio | $54.94 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $8.30 | $12.96 |
| 52 Week High | $24.99 | $20.90 |
| Indicator | PLAY | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 39.58 | 38.32 |
| Support Level | N/A | $13.55 |
| Resistance Level | $10.81 | $14.55 |
| Average True Range (ATR) | 0.51 | 0.48 |
| MACD | -0.11 | -0.03 |
| Stochastic Oscillator | 22.39 | 0.61 |
Dave & Buster's Entertainment Inc is an owner and operator of entertainment and dining venues in North America that offer experiences for both adults and families under the Dave & Buster's and Main Event brands. The company combines various forms of entertainment, including games, bowling, and watching live sports and other televised events, with a full menu of entrees and appetizers and a selection of alcoholic and non alcoholic beverages, all in one location. Its concept focuses on providing customers the opportunity to Eat, Drink, Play, and Watch, appealing to a balanced mix of adults, families, and teenagers. The company also operates internationally in the early stage as a franchisor of the Dave & Buster's brand.
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.